Figures & data
Table 1 Demographic and clinical characteristics of 78 patients with ankylosing spondylitis at baseline and at the end of follow-up in December 2009
Table 2 Baseline and end of follow-up results in 22 patients with ankylosing spondylitis receiving etanercept 50 mg every other week and 21 patients receiving 50 mg weekly